2 completed, 1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow Single blood draw: new trials by email Literature Review of Single blood draw trials Research Report on Single blood draw
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prognostic Markers of Inflammation in Infants Undergoing Cardiopulmonary Bypass Single blood draw, Multiple blood draws - Congenital Heart Defect, Cardiopulmonary Bypass | Completed | University of Oklahoma | 38 | 2017-06-04 | 2019-04-30 | |
| Endothelial Microparticles: A Novel Marker of Vascular Dysfunction Flow-mediated dilation, single blood draw - Chronic Kidney Disease | Completed | University of Colorado, Denver | 90 | 2014-09-01 | 2018-02-28 | |
| Study Evaluating Inhibitor Specificity in Hemophilia A single blood draw - Hemophilia A | Phase 4 | Withdrawn | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-11-01 | 2012-06-28 |
Cardiac Output, Low (1) · Heart Defects, Congenital (1) · Hemophilia A (1) · Inflammation (1) · Renal Insufficiency, Chronic (1)
University of Colorado, Denver (1) · University of Oklahoma (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
United States (3) · Belgium (1) · France (1) · Germany (1) · Italy (1) · Spain (1) · United Kingdom (1)
Hala Chaaban, MD (1) · Joshua M Thurman, MD (1)
UL1TR001082 (1)